Genus holds gloomy guidance as tough conditions persist

22nd Feb 2024 08:42

(Sharecast News) - There were few surprises in Genus's interim results on Thursday after a detailed trading update from the animal genetics company just last week, as it reported a 31% drop in adjusted profits as expected.

Read more

London close: Stocks manage gains despite UK recession news

15th Feb 2024 14:55

(Sharecast News) - London markets had a mixed but ultimately positive day of trading on Thursday, despite news that the UK fell into a technical recession at the end of 2023.

Read more

Genus tumbles after warning on full-year profits

15th Feb 2024 09:07

(Sharecast News) - Genus shares tumbled on Thursday as the animal genetics company warned on full-year profits.

Read more

London close: Stocks mixed as investors digest Autumn Statement

22nd Nov 2023 15:12

(Sharecast News) - London markets closed with a mixed performance on Wednesday, influenced by the Chancellor's Autumn Statement and big moves from the likes of Sage and Kingfisher.

Read more

Genus' ABS unit has 'challenging start' to FY, PIC trading remains 'robust'

22nd Nov 2023 10:13

(Sharecast News) - Animal genetics firm Genus said its ABS division has had "a challenging start" to the year but noted that PIC trading in the roughly five months ended 21 November had been "robust".

Read more

Genus full-year revenue rises, profits remain static

7th Sep 2023 10:17

(Sharecast News) - Agricultural biotechnology firm Genus reported 10% growth in group revenue in its preliminary results on Thursday, to £689.7m, or 16% when translated to constant currency rates.

Read more

Genus cuts full-year profit outlook

16th May 2023 07:13

(Sharecast News) - Animal genetics company Genus cut its full-year profit outlook on Tuesday as it pointed to "very challenging" market conditions in the porcine business in China.

Read more

Director dealings: Genus announces new CEO's compensation, AstraZeneca chair spends £0.23m

2nd May 2023 12:15

(Sharecast News) - Livestock genetics company Genus saw its shares weaken on Tuesday afternoon after it announced the agreed reward arrangements for its incoming CEO, Jorgen Kokke.

Read more

Genus names Jorgen Kokke as its next CEO

3rd Apr 2023 07:26

(Sharecast News) - Animal genetics company Genus announced the appointment of Jorgen Kokke as its chief executive officer-designate on Monday, with plans to take over as CEO on 1 July, succeeding Stephen Wilson, who would retire on 30 September.

Read more

Genus CEO Wilson to retire

23rd Feb 2023 07:27

(Sharecast News) - Animal genetics company Genus said chief executive Stephen Wilson has decided to retire as the company also posted a 14% rise in annual profits as it hoped for a price rebound this summer.

Read more

Genus sees FY earnings in line with expectations

23rd Nov 2022 08:05

(Sharecast News) - Animal genetic company Genus said it expected annual pre-tax profits to be in line with expectations with performance weighted to the second half.

Read more

Genus profits dented by PIC China challenges

8th Sep 2022 09:41

(Sharecast News) - Animal genetics company Genus posted a drop in full-year profit on Thursday as it took a hit from challenging market conditions in its PIC China business.

Read more

Genus FY profits slip as weak Chinese PIC performance weighs

24th Feb 2022 09:19

(Sharecast News) - Biotechnology company Genus said on Thursday that full-year profits had slipped in 2021 as the group's performance was impacted by the performance of its PIC unit in China.

Read more

Director dealings: Genus chairman makes share purchase

25th Nov 2021 15:26

(Sharecast News) - Genus revealed on Thursday that chairman Iain Ferguson had acquired 1,000 ordinary shares in the FTSE 250-listed biotechnology firm.

Read more

Genus sees FY profit 'moderately' below its expectations

24th Nov 2021 07:54

(Sharecast News) - Animal genetics company Genus said on Wednesday that based on current trading, especially in China, pre-tax profit for 2022 is set to be "moderately lower" than its previous expectations.

Read more